MATHEIS DENNIS purchased 50.5% of their position (14.43K shares) of DARIOHEALTH CORP. on the open market
Open‑market purchase worth $100.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/28/2026ACC: 0001104659-26-087626
+15.35K
Net shares
Net buyer
$118.4K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
15.39K acquired · 50.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+965.00
Price / share
$19.10
Trade value
$18.43K
% of position
3.5%
8/12/2024
27.63K→28.60K
Common Stock
Direct
Shares
+14.43K
Price / share
$6.93
Trade value
$100K
% of position
50.5%
7/23/2026
28.60K→43.03K
Total
Net shares
+15.39K
Net value
$118.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2024 | C · Conversion | +965.00 | $19.10 | $18.43K | 3.5% | 27.63K | 28.60K |
| Common Stock Direct | 7/23/2026 | P · Purchase | +14.43K | $6.93 | $100K | 50.5% | 28.60K | 43.03K |
| Total | +15.39K | $118.43K | ||||||
Derivative Transactions1
Series B-2 Preferred Stock
Direct
Converts to
Common Stock
965.00 shares
Shares
−50.00
Strike price
1000
Held after
0.00
Exercisable
—
8/12/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B-2 Preferred Stock Direct | Common Stock965.00 shares | 8/12/2024 | C · Conversion | −50.00 | 1000 | — | 0.00 |